RCG
CLBT icon

Rock Creek Group’s Cellebrite CLBT Stock Holding History

Rock Creek Group’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Buy
200,000
+50,000
+33% +$661K 0.29% 26
2026
Q1 		$2.07M Hold
150,000
– – 0.21% 27
2025
Q4 		$2.7M Buy
+150,000
New +$2.69M 0.3% 26

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Rock Creek Group's CLBT Position: Q2 2026 in Review

Rock Creek Group increased its Cellebrite (CLBT) stake by 33% in Q2 2026, buying an estimated $661K and bringing the position to 200,000 shares worth $2.92M. The position accounts for 0.29% of the portfolio, ranked #26.

Rock Creek Group first reported a position in CLBT in Q4 2025 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Rock Creek Group held 200,000 shares of Cellebrite worth $2.92M as of Q2 2026.
  • Rock Creek Group bought 50,000 Cellebrite shares in Q2 2026, an estimated $661K.
  • Cellebrite made up 0.29% of Rock Creek Group's portfolio in Q2 2026, its #26 holding.
  • Rock Creek Group first reported a position in Cellebrite in Q4 2025 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Rock Creek Group's 13F filing for Q2 2026, filed 3 Aug 2026.